Post-approval studies (Phase 4)Study completedNCT00557232What this trial is testingIntraocular Bevacizumab (Avastin) for Rubeosis IridisWho this might be right forGlaucomaRubeosis Iridis Instituto de Olhos de Goiania 25
Early research (Phase 1)Study completedNCT00295828What this trial is testingA Pilot Study for the Treatment of Iris Neovascularization With MacugenWho this might be right forIris NeovascularizationDiabetic Retinopathy Hermann Eye Center 10
Testing effectiveness (Phase 2)Study completedNCT00470977What this trial is testingTreatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyWho this might be right forCoats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more Manhattan Eye, Ear & Throat Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT00211471What this trial is testingTreatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).Who this might be right forSevere Diabetic RetinopathyCentral Retinal Vein OcclusionChronic Inflammation+1 more Manhattan Eye, Ear & Throat Hospital
Early research (Phase 1)Study completedNCT01069341What this trial is testingUse of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract SurgeryWho this might be right forRubeosis IridisProliferative Diabetic Retinopathy Bhagat, Neelakshi, M.D., M.P.H. 4
Large-scale testing (Phase 3)Study completedNCT02641457What this trial is testingIntravitreal Aflibercept or Ranibizumab for Rubeosis IridisWho this might be right forGlaucomaRubeosis Iridis Instituto de Olhos de Goiania 2